Pitfall of 18F-PSMA PyL PET/CT Imaging of a Displaced Urinary Bladder as Recurrent Prostate Malignancy

被引:0
|
作者
Tewari, Sanjit O. [1 ]
Metwalli, Zeyad A. [2 ]
Xu, Guofan [1 ,3 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Nucl Med, Div Diagnost Imaging, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Intervent Radiol, Div Diagnost Imaging, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Nucl Med, Div Diagnost Imaging, Unit Number 1483,1400 Pressler St, Houston, TX 77030 USA
关键词
PSMA; PSMA PET; lymphocele;
D O I
10.1097/RLU.0000000000004876
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
We herein present a potential pitfall in the setting of restaging PSMA PyL PET/CT. In this case, there is large non-PSMA-avid cystic structure in the mid pelvis, probably representing a postprostatectomy lymphocele, which was mistaken for the urinary bladder, resulting in the displaced and somewhat crescentic urinary bladder to be deemed recurrence. Subsequently, biopsy and retrospective review of images confirms displaced urinary bladder containing physiologic excreted activity.
引用
收藏
页码:1071 / 1072
页数:2
相关论文
共 50 条
  • [1] Comparison of 68Ga-PSMA PET/CT and 18F-PSMA PET/CT of a Patient with Prostate Cancer Recurrence on Urinary Bladder Wall
    Soydal, Cigdem
    Demir, Burak
    Sutcu, Gizem
    Araz, Mine
    Kucuk, Nuriye Ozlem
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2023, 32 (02) : 150 - 152
  • [2] Ductal Variant of Prostate Cancer Serial Imaging With 18F-PSMA PET/CT
    Alabed, Yazan Z.
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (11) : E551 - E552
  • [3] Management impact and detection rate of 18F-Prostate-Specific Membrane Antigen (18F-PSMA) PET/CT imaging for biochemically recurrent prostate cancer
    Panagiotidis, E.
    Paschali, A.
    Klampatsas, A.
    Pipintakou, A.
    Makridou, A.
    Chatzipavlidou, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S174 - S174
  • [4] 18F-PSMA 1007 Brain PET/CT Imaging in Glioma Recurrence
    Marafi, Fahad
    Sasikumar, Arun
    Fathallah, Wael
    Esmail, Abdulredh
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (01) : E61 - E62
  • [5] The value of 18F-PSMA PET/CT in the diagnosis and prognosis of primary prostate cancer
    Wang, Zhuonan
    Zheng, Anqi
    Gao, Jungang
    Yuan, Wang
    Duan, Xiaoyi
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [6] Incidental Airway Findings on PET/CT with 18F-PSMA
    Orciuolo, Jason
    Sharma, Akash
    Parent, Ephraim E.
    Accurso, Joseph M.
    Jain, Manoj K.
    Young, Jason R.
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (06) : 993 - 993
  • [7] Spectrum of Metabolic and Angiogenic Imaging with 18F-FDOPA and 18F-PSMA 1007 PET/CT in the Evaluation of Recurrent Glioblastoma Multiforme
    Sharjeel Usmani
    Fahad Marafi
    Alyaa Sadeq
    Abdulredha esmail
    Nuclear Medicine and Molecular Imaging, 2025, 59 (2) : 156 - 157
  • [8] 18F-FDG or 68Ga/18F-PSMA PET/CT in recurrent renal cancer?
    Laura Evangelista
    Lea Cuppari
    Clinical and Translational Imaging, 2018, 6 : 329 - 330
  • [9] 18F-FDG or 68Ga/18F-PSMA PET/CT in recurrent renal cancer?
    Evangelista, Laura
    Cuppari, Lea
    CLINICAL AND TRANSLATIONAL IMAGING, 2018, 6 (04) : 329 - 330
  • [10] Primary Prostatic Stromal Sarcoma on 18F-PSMA PET/CT
    Chen, Meiyan
    Dong, Yanliang
    Xu, Baixuan
    Liu, Yachao
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (10) : 956 - 958